Edge Wealth Management’s Sophiris Bio, Inc. SPHS Stock Holding History

Edge Wealth Management’s Portfolio SPHS Stock Details SPHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,000	Closed	-$2K	–	652
2019 Q1	$2K	Hold	2,000	–	–	﹤0.01%	529
2018 Q4	$2K	Hold	2,000	–	–	﹤0.01%	538
2018 Q3	$6K	Hold	2,000	–	–	﹤0.01%	497
2018 Q2	$6K	Hold	2,000	–	–	﹤0.01%	481
2018 Q1	$4K	Hold	2,000	–	–	﹤0.01%	480
2017 Q4	$4K	Hold	2,000	–	–	﹤0.01%	463
2017 Q3	$4K	Hold	2,000	–	–	﹤0.01%	465
2017 Q2	$4K	Hold	2,000	–	–	﹤0.01%	457
2017 Q1	$6K	Hold	2,000	–	–	﹤0.01%	409
2016 Q4	$6K	Hold	2,000	–	–	﹤0.01%	389
2016 Q3	$6K	Buy	+2,000	New	+$7.52K	﹤0.01%	387

Other funds holding SPHS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BRR OpCo Columbus, Ohio $814M AUM 9.75% 1-Year Est. Return

ACM

Alpha Capital Management Austin, Texas $690M AUM 22.82% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Edge Wealth Management's SPHS Position: Q2 2019 in Review

Edge Wealth Management sold out of Sophiris Bio, Inc. (SPHS) in Q2 2019, closing a stake of 2,000 shares — an estimated $2K sold.

Edge Wealth Management first reported a position in SPHS in Q3 2016 and held it in 11 quarters. The position peaked at $6K in Q3 2018. 22 funds tracked by Wall St. Rank hold SPHS as of Q2 2019.

Edge Wealth Management reported no remaining Sophiris Bio, Inc. position as of Q2 2019 after selling out during the quarter.
Edge Wealth Management sold 2,000 Sophiris Bio, Inc. shares in Q2 2019, an estimated $2K.
Edge Wealth Management first reported a position in Sophiris Bio, Inc. in Q3 2016 and held it in 11 quarters.
Edge Wealth Management's Sophiris Bio, Inc. position peaked at $6K in Q3 2018.
22 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q2 2019.

Based on Edge Wealth Management's 13F filing for Q2 2019, filed 15 Jul 2019.